Draupnir Bio intends to develop a new type of cholesterol-lowering medicine that prevents blood clots in the heart more effectively than the current medicine. The company is developing a platform for exploring the glycome to develop novel therapeutics, based on array technology, protein chemistry, a... Read more
Novo Nordisk
553 followers
Johnson & Johnson
684 followers
AbbVie
362 followers
ARS Pharmaceuticals
2 followers
Prologue Medicines
1 follower
Novel Bio
1 follower
Bristol-Myers Squibb
322 followers
Thermo Fisher Scientific
289 followers
Biogen
168 followers
Boehringer Ingelheim
160 followers
Leo Pharma
73 followers
Genmab
55 followers